Alberto Gabizon
Vorstandsvorsitzender bei Lipomedix Pharmaceuticals Ltd.
Aktive Positionen von Alberto Gabizon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Gründer | - | - | |
Präsident | 05.08.2019 | - |
Karriereverlauf von Alberto Gabizon
Statistik
International
Israel | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Health Technology |
- Börse
- Insiders
- Alberto Gabizon
- Erfahrung